Protective Effects of N-Acetylcysteine and β -Glucan Pretreatment on Oxidative Stress in Cecal Ligation and Puncture Model of Sepsis

REFERENCES

• Adrie C, Pinsky M R. The inflammatory balance in human sepsis. Intensive Care Med 2000; 26: 364–375
   PubMedGoogle Scholar
• Marsh C B, Wewers M D. The pathogenesis of sepsis: factors that modulate the response to gram-negative bacterial infection. Clin Chest Med 1996; 17: 183–197
   PubMed Web of Science ®Google Scholar
• Gutteridge J MC, Mitchell J. Redox imbalance in the critically ill. Br Med Bull 1999; 55: 49–75
   PubMed Web of Science ®Google Scholar
• Macdonald J, Galley H F, Webster N R. Oxidative stress and gene expression in sepsis. Br J Anaesth 2003; 90: 221–232
   PubMed Web of Science ®Google Scholar
• Lovat R, Preiser J C. Antioxidant therapy in intensive care. Curr Opin Crit Care 2003; 9: 266–270
   PubMedGoogle Scholar
• Spapen H, Zhang H, Demanet C, et al. Does N-acetyl-L-cysteine influence cytokine response during early human septic shock. Chest 1998; 113: 1616–1624
   PubMedGoogle Scholar
• Verhasselt V, Vanden Berghe W, Vanderheyde N, et al. N-Acetyl-L-cysteine inhibits primary human T cell responses at the dendritic cell level: association with NF-kB inhibition. J. Immunol 1999; 162: 2569–2574
   PubMed Web of Science ®Google Scholar
• Cisneros R L, Gibson F C, Tzianabos A O. Passive transfer of poly-(1–6)-beta-glucotriosyl-(1–3)-beta-glucopyranose glucan protection against lethal infection in an animal model of intra-abdominal sepsis. Infect Immun 1996; 64: 2201–2205
   PubMed Web of Science ®Google Scholar
• Onderdonk A B, Cisneros R L, Hinkson P, et al. Anti-infective effect of poly-beta 1–6-glucotriosyl-beta 1–3-glucopyranose glucan in vivo. Infect Immun 1992; 60: 1642–1647
   PubMed Web of Science ®Google Scholar
• Sener G, Toklu H, Ercan F, et al. Protective effect of beta-glucan against oxidative organ injury in a rat model of sepsis. Int Immunopharmacol 2005; 5: 1387–1396
   PubMed Web of Science ®Google Scholar
• Babayigit H, Kucuk C, Sozuer E, Yazici C, et al. Protective effect of beta-glucan on lung injury after cecal ligation and puncture in rats. Intensive Care Med 2005; 31: 865–870
   PubMed Web of Science ®Google Scholar
• Williams D L, Ha T, Li C, et al. Inhibiting early activation of tissue nuclear factor-EB and nuclear factor interleukin 6 with (1–3)-h-d-glucan increases long-term survival in polymicrobial sepsis. Surgery 1999; 126: 54–65
   PubMed Web of Science ®Google Scholar
• Dhainaut J F, Marin N, Mignon A, et al. Hepatic response to sepsis: interaction between coagulation and inflammatory processes. Crit Care Med 2001; 29(7 Suppl.)S42–S47
   Google Scholar
• Baker C C, Chaudry I H, Gaines H O, et al. Evaluation of factors affecting mortality rate after sepsis in a murine cecal ligation and puncture model. Surgery 1983; 94: 331–335
   PubMed Web of Science ®Google Scholar
• Fridovich I. Superoxide radical: an endogenous toxicant. Annu Rev Pharmacol Toxicol 1983; 23: 239–257
   PubMed Web of Science ®Google Scholar
• Beutler E. Red Cell Metabolism, 2nd edition. Grune and Stratton, New York 1975; 261–265
   Google Scholar
• Ohkawa H, Ohishi N, Tagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 1979; 95: 351–358
   PubMed Web of Science ®Google Scholar
• Lowry O H, Rosebrough N J, Farr A L, et al. Protein measurement with the folin phenol reagent. J Biol Chem 1951; 193: 265–275
   PubMed Web of Science ®Google Scholar
• Angus D C, Linde-Zwirble W T, Lidicker J, et al. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med 2001; 29: 1303–1310
   PubMed Web of Science ®Google Scholar
• Bochud P Y, Calandra T. Pathogenesis of sepsis: new concepts and implications for future treatment. BMJ 2003; 326: 262–266
   PubMed Web of Science ®Google Scholar
• Walley K R, Lukacs N W, Standiford T J, et al. Balance of inflammatory cytokines related to severity and mortality of murine sepsis. Infect Immun 1996; 64: 4733–4738
   PubMed Web of Science ®Google Scholar
• Cao Q, Mak K M, Lieber C S. Dilinoleoylphosphatidylcholine decreases LPS-induced TNF-alpha generation in Kupffer cells of ethanol-fed rats: respective roles of MAPKs and NF-kappaB. Biochem Biophys Res Commun 2002; 294: 849–8453
   PubMedGoogle Scholar
• Damas P, Ledoux D, Nys M, et al. Cytokine serum level during severe sepsis in human IL-6 as a marker of severity. Ann Surg 1992; 215: 356–362
   PubMed Web of Science ®Google Scholar
• Neidhardt R, Keel M, Steckholzer U, et al. Relationship of interleukin-10 plasma levels to severity of injury and clinical outcome in injured patients. J Trauma 1997; 42: 863–870
   PubMedGoogle Scholar
• Pinsky M R. Antioxidant therapy for severe sepsis: promise and perspective. Crit Care Med 2003; 31: 2697–2698
   PubMedGoogle Scholar
• Paterson R L, Galley H F, Webster N R. The effect of N-acetylcysteine on nuclear factor-kappa B activation, interleukin-6, interleukin-8, and intercellular adhesion molecule-1 expression in patients with sepsis. Crit Care Med 2003; 31: 2574–2578
   PubMed Web of Science ®Google Scholar
• Brown G D, Herre J, Williams D L, et al. Dectin-1 mediates the biological effects of beta-glucans. J Exp Med 2003; 197: 1119–1124
   PubMed Web of Science ®Google Scholar
• Scandalios J G. Oxygen stress and superoxide dismutases. Plant Physiol 1993; 101: 7–12
   PubMed Web of Science ®Google Scholar
• Liaudet L, Mapley J G, Soriano F G, et al. Inosine reduces systemic inflammation and improves survival in septic shock induced by cecal ligation and puncture. Am J Respir Crit Care Med 2001; 164: 1213–1220
   PubMed Web of Science ®Google Scholar
• Hartley D P, Kolaja K L, Reichard J, et al. 4-Hydroxynonenal and malondialdehyde hepatic protein adducts in rats treated with carbon tetrachloride: immunochemical detection and lobular localization. Toxicol Appl Pharmacol 1999; 161: 23–33
   PubMed Web of Science ®Google Scholar
• Sampey B P, Korourian S, Ronis M J, et al. Immunohistochemical characterization of hepatic malondialdehyde and 4-hydroxynonenal modified proteins during early stages of ethanol-induced liver injury. Alcohol Clin Exp Res 2003; 27: 1015–1022
   PubMedGoogle Scholar